tiprankstipranks
Surrozen, Inc.: Q3 2024 Earnings Overview
PremiumCompany AnnouncementsSurrozen, Inc.: Q3 2024 Earnings Overview
2M ago
Surrozen reports Q3 EPS (44c) vs. ($5.14) last year
Premium
The Fly
Surrozen reports Q3 EPS (44c) vs. ($5.14) last year
3M ago
Surrozen, TCGFB announce strategic research collaboration
Premium
The Fly
Surrozen, TCGFB announce strategic research collaboration
3M ago
Surrozen initiates dosing of first patient in Phase 1b trial of SZN-043
PremiumThe FlySurrozen initiates dosing of first patient in Phase 1b trial of SZN-043
8M ago
Surrozen presents data demonstrating potentialfor Wnt mimetic technologies
Premium
The Fly
Surrozen presents data demonstrating potentialfor Wnt mimetic technologies
9M ago
Surrozen files to sell 1.09M shares of common stock for holders
Premium
The Fly
Surrozen files to sell 1.09M shares of common stock for holders
10M ago
Surrozen Highlights SZN-043 Data on Safety and Liver Function
PremiumCompany AnnouncementsSurrozen Highlights SZN-043 Data on Safety and Liver Function
10M ago
Surrozen announces up to $192.5M private placement
Premium
The Fly
Surrozen announces up to $192.5M private placement
10M ago
Surrozen announces safety, pharmacodynamic, liver function data for SZN-043
Premium
The Fly
Surrozen announces safety, pharmacodynamic, liver function data for SZN-043
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100